ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
2,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
3,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
3,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
4,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5,1,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,2,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
7,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
7,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
8,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
